
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators' scrutiny over its import duties. The new hub is expected …